| 15.94 0.45 (2.91%) | 06-15 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.51 |
1-year : | 23.95 |
| Resists | First : | 17.56 |
Second : | 20.51 |
| Pivot price | 15.11 |
|||
| Supports | First : | 15.42 |
Second : | 14.1 |
| MAs | MA(5) : | 15.3 |
MA(20) : | 15.04 |
| MA(100) : | 15.38 |
MA(250) : | 12.36 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 81.3 |
D(3) : | 63.5 |
| RSI | RSI(14): 58 |
|||
| 52-week | High : | 17.56 | Low : | 8.63 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MRNY ] has closed Bollinger Bands are 39.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 15.99 - 16.06 | 16.06 - 16.12 |
| Low: | 15.34 - 15.41 | 15.41 - 15.49 |
| Close: | 15.82 - 15.93 | 15.93 - 16.05 |
This actively managed exchange-traded fund, known as the YieldMax MRNA Option Income Strategy ETF (MRNY), is engineered to deliver consistent weekly income. It achieves this by strategically issuing call options or initiating call spreads that are tied to shares of MRNA. The fundamental design of this approach is to collect premiums from these options, while also providing investors with a means to participate in any upward movement in MRNA's stock valuation.
Sat, 13 Jun 2026
YieldMax MRNA option income strategy ETF announces weekly distribution of $0.2061 - MSN
Sat, 30 May 2026
YieldMax MRNA option income strategy ETF announces weekly distribution of $0.2357 - MSN
Wed, 20 May 2026
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs - markets.businessinsider.com
Wed, 08 Apr 2026
MRNY: Strong Income Run Masks Rising Downside Risk (NYSEARCA:MRNY) - Seeking Alpha
Thu, 29 Jan 2026
3 ETFs Catapulting Beyond the S&P to Start the Year - MarketBeat
Thu, 22 Jan 2026
MRNY: Jumping On Big Moderna Move - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Income
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|